Ht-Logo-gigapixel-icon
Tuesday, November 5, 2024
Canada’s Politics and Government News Source Since 1989
Tuesday, November 5, 2024 | Latest Paper

Trina Racine

Dr. Trina Racine received her PhD in microbiology and immunology from Dalhousie University in 2010. She then joined the special pathogens program at the National Microbiology Laboratory, part of the Public Health Agency of Canada. While at the NML Dr. Racine worked on the development of vaccines and therapeutics for various emerging and re-emerging infectious diseases, including Ebola, Zika and MERS. Dr. Racine has coordinated clinical trials and has provided diagnostic support to the Ebola outbreak in West Africa in 2014-2016. Prior to joining VIDO, Dr. Racine was a scientific and regulatory affairs consultant for GeneOne Life Science, Inc., a South Korean based biopharmaceutical company.

Building Canada’s vaccine manufacturing infrastructure, more than just walls

Opinion | BY TRINA RACINE | September 13, 2021
Canada's Chief Health Medical Theresa Tam, pictured April 2, 2020, on the Hill at a press conference. The Hill Times photograph by Andrew Meade
Opinion | BY TRINA RACINE | September 13, 2021
Opinion | BY TRINA RACINE | September 13, 2021
Canada's Chief Health Medical Theresa Tam, pictured April 2, 2020, on the Hill at a press conference. The Hill Times photograph by Andrew Meade
Opinion | BY TRINA RACINE | September 13, 2021
Canada's Chief Health Medical Theresa Tam, pictured April 2, 2020, on the Hill at a press conference. The Hill Times photograph by Andrew Meade
Opinion | BY TRINA RACINE | September 13, 2021
Opinion | BY TRINA RACINE | September 13, 2021
Canada's Chief Health Medical Theresa Tam, pictured April 2, 2020, on the Hill at a press conference. The Hill Times photograph by Andrew Meade